BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Quirion B, Bergeron F, Blais V, Gendron L. The Delta-Opioid Receptor; a Target for the Treatment of Pain. Front Mol Neurosci 2020;13:52. [PMID: 32431594 DOI: 10.3389/fnmol.2020.00052] [Cited by in Crossref: 16] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Sun Q, Li Z, Wang Z, Wang Q, Qin F, Pan H, Lin W, Mu X, Wang Y, Jiang Y, Ji J, Lu Z. Immunosuppression by opioids: Mechanisms of action on innate and adaptive immunity. Biochem Pharmacol 2023;209:115417. [PMID: 36682388 DOI: 10.1016/j.bcp.2023.115417] [Reference Citation Analysis]
2 Guan Q, Velho RV, Sehouli J, Mechsner S. Endometriosis and Opioid Receptors: Are Opioids a Possible/Promising Treatment for Endometriosis? Int J Mol Sci 2023;24. [PMID: 36675147 DOI: 10.3390/ijms24021633] [Reference Citation Analysis]
3 Marinho ADO, Brito JDS, da Costa JA, da Silva AR, da Silva SP, de Amorim LC, Correia MTDS, Paiva PMG, de Oliveira AM, Patriota LLDS, Napoleão TH. Schinus terebinthifolia leaf lectin has central and peripheral antinociceptive action mediated by its carbohydrate-recognition domain and delta-opioid receptors. Journal of Ethnopharmacology 2023;301:115817. [DOI: 10.1016/j.jep.2022.115817] [Reference Citation Analysis]
4 Nimbalkar S, Guo X, Colón A, Jackson M, Akanda N, Patel A, Grillo M, Hickman JJ. Development of a functional human induced pluripotent stem cell-derived nociceptor MEA system as a pain model for analgesic drug testing. Front Cell Dev Biol 2023;11:1011145. [PMID: 36936691 DOI: 10.3389/fcell.2023.1011145] [Reference Citation Analysis]
5 Spence AL, Cogan PS, Calderon BB, Kaye AD, Potthoff KL. Basic pharmacology of opioid substances. Substance Use and Addiction Research 2023. [DOI: 10.1016/b978-0-323-98814-8.00003-2] [Reference Citation Analysis]
6 Xu C, Cheng Y, Han M, Tao Y, Liu J. The Agonist of Adenosine A1 Receptor Induced Desensitization of delta Opioid receptor-mediated Raf-1/MEK/ERK Signaling by Feedback Phosphorylation of Raf-1-Ser289/296/301. Neurochem Res 2022. [DOI: 10.1007/s11064-022-03843-2] [Reference Citation Analysis]
7 Ślusarz MJ. Molecular insights into the mechanism of sugar-modified enkephalin binding to opioid receptors. Computational Biology and Chemistry 2022. [DOI: 10.1016/j.compbiolchem.2022.107783] [Reference Citation Analysis]
8 Sudradjat SE, Timotius KH. Pharmacological Properties and Phytochemical Components of Elaeocarpus: A Comparative Study. Phytomedicine Plus 2022. [DOI: 10.1016/j.phyplu.2022.100365] [Reference Citation Analysis]
9 Xu C, Cheng Y, Tao Y, Liu J. The agonist of adenosine A1 receptor induced desensitization of delta opioid receptor-mediated Raf-1/MEK/ERK signaling by feedback phosphorylation of Raf-1-Ser289/296/301.. [DOI: 10.21203/rs.3.rs-2205407/v1] [Reference Citation Analysis]
10 Higginbotham JA, Markovic T, Massaly N, Morón JA. Endogenous opioid systems alterations in pain and opioid use disorder. Front Syst Neurosci 2022;16:1014768. [PMID: 36341476 DOI: 10.3389/fnsys.2022.1014768] [Reference Citation Analysis]
11 Gaborit M, Massotte D. Les hétéromères impliquant le récepteur opioïde δ : des cibles potentielles pour soulager la douleur chronique ? Douleur analg 2022;35:153-162. [DOI: 10.3166/dea-2022-0224] [Reference Citation Analysis]
12 Eller OC, Willits AB, Young EE, Baumbauer KM. Pharmacological and non-pharmacological therapeutic interventions for the treatment of spinal cord injury-induced pain. Front Pain Res 2022;3. [DOI: 10.3389/fpain.2022.991736] [Reference Citation Analysis]
13 Dalefield ML, Scouller B, Bibi R, Kivell BM. The Kappa Opioid Receptor: A Promising Therapeutic Target for Multiple Pathologies. Front Pharmacol 2022;13:837671. [DOI: 10.3389/fphar.2022.837671] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Quirion B, Beaulieu C, Côté L, Parent JL, Gendron L. Distribution of delta and mu opioid receptor mRNA in rodent dorsal root ganglia neurons. Eur J Neurosci 2022. [PMID: 35674691 DOI: 10.1111/ejn.15733] [Reference Citation Analysis]
15 Vicario N, Denaro S, Turnaturi R, Longhitano L, Spitale FM, Spoto S, Marrazzo A, Zappalà A, Tibullo D, Li Volti G, Chiechio S, Pasquinucci L, Parenti R, Parenti C. Mu and Delta Opioid Receptor Targeting Reduces Connexin 43-Based Heterocellular Coupling during Neuropathic Pain. Int J Mol Sci 2022;23:5864. [PMID: 35682543 DOI: 10.3390/ijms23115864] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
16 Somogyi AA, Musolino ST, Barratt DT. New pharmacological perspectives and therapeutic options for opioids: Differences matter. Anaesth Intensive Care 2022;:310057X211063891. [PMID: 35112584 DOI: 10.1177/0310057X211063891] [Reference Citation Analysis]
17 Blebea NM. Opioids, opioid receptors and therapeutic implications. Farmacist ro 2022;6:31. [DOI: 10.26416/farm.209.6.2022.7303] [Reference Citation Analysis]
18 Carranza-aguilar CJ, Espinosa-riquer ZP, Martínez-cuevas FL, Cruz SL. Opioid Receptors and Neuronal Signal Transduction. Opioids 2022. [DOI: 10.1007/978-3-031-09936-6_9] [Reference Citation Analysis]
19 Chen C, Ding H, Mabry KM, Ko M. Enhanced antidepressant-like effects of a delta opioid receptor agonist, SNC80, in rats under inflammatory pain. Pharmacology Biochemistry and Behavior 2022. [DOI: 10.1016/j.pbb.2022.173341] [Reference Citation Analysis]
20 Porta A, Rodríguez L, Bai X, Batallé G, Roch G, Pouso-Vázquez E, Balboni G, Pol O. Hydrogen Sulfide Inhibits Inflammatory Pain and Enhances the Analgesic Properties of Delta Opioid Receptors. Antioxidants (Basel) 2021;10:1977. [PMID: 34943080 DOI: 10.3390/antiox10121977] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
21 Leduc-Pessah H, Trang T. Tackling the opioid crisis: Novel mechanisms and clinical perspectives. J Neurosci Res 2021. [PMID: 34672010 DOI: 10.1002/jnr.24964] [Reference Citation Analysis]
22 Piras S, Murineddu G, Loriga G, Carta A, Battistello E, Merighi S, Gessi S, Corona P, Asproni B, Ibba R, Temml V, Schuster D, Pinna GA. Biological Effects on μ-Receptors Affinity and Selectivity of Arylpropenyl Chain Structural Modification on Diazatricyclodecane Derivatives. Molecules 2021;26:5448. [PMID: 34576918 DOI: 10.3390/molecules26185448] [Reference Citation Analysis]
23 Terashvili M, Talluri B, Palangmonthip W, Iczkowski KA, Sanvanson P, Medda BK, Banerjee B, Cunningham CW, Sengupta JN. Peripheral antinociceptive effects of a bifunctional μ and δ opioid receptor ligand in rat model of inflammatory bladder pain. Neuropharmacology 2021;196:108701. [PMID: 34256047 DOI: 10.1016/j.neuropharm.2021.108701] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Tavares I, Costa-pereira JT, Martins I. Monoaminergic and Opioidergic Modulation of Brainstem Circuits: New Insights Into the Clinical Challenges of Pain Treatment? Front Pain Res 2021;2:696515. [DOI: 10.3389/fpain.2021.696515] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
25 Levran O, Randesi M, Adelson M, Kreek MJ. OPRD1 SNPs associated with opioid addiction are cis-eQTLs for the phosphatase and actin regulator 4 gene, PHACTR4, a mediator of cytoskeletal dynamics. Transl Psychiatry 2021;11:316. [PMID: 34031368 DOI: 10.1038/s41398-021-01439-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
26 Lee SW, Han HC. Methylene Blue Application to Lessen Pain: Its Analgesic Effect and Mechanism. Front Neurosci 2021;15:663650. [PMID: 34079436 DOI: 10.3389/fnins.2021.663650] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
27 Li Y, Bao Y, Zheng H, Qin Y, Hua B. Can Src protein tyrosine kinase inhibitors be combined with opioid analgesics? Src and opioid-induced tolerance, hyperalgesia and addiction. Biomed Pharmacother 2021;139:111653. [PMID: 34243625 DOI: 10.1016/j.biopha.2021.111653] [Reference Citation Analysis]
28 Kuppalli S, Seth R, Orhurhu V, Urits I, Kaye AD, Hunter C, Gulati A, Adekoya P, Kaye AM, Jones MR. Recent Advances in the Treatment of Opioid Use Disorder. Curr Pain Headache Rep 2021;25:23. [PMID: 33693999 DOI: 10.1007/s11916-021-00941-8] [Reference Citation Analysis]
29 Chen M, Wu S, Shen B, Fan Q, Zhang R, Zhou Y, Zhang P, Wang L, Zhang L. Activation of the δ opioid receptor relieves cerebral ischemic injury in rats via EGFR transactivation. Life Sci 2021;273:119292. [PMID: 33667516 DOI: 10.1016/j.lfs.2021.119292] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]